Serum Metabolomics Analysis Reveals a Distinct Metabolic Profile of Patients with Primary Biliary Cholangitis
Abstract Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease associated with profound metabolic changes. The purpose of this study was to identify a distinctive metabolic signature from the training set with 29 PBC patients, 30 hepatitis B virus (HBV)-caused cirrhosis (HBC) and 4...
Guardado en:
Autores principales: | Juan Hao, Tao Yang, Yang Zhou, Guo-Yuan Gao, Feng Xing, Yuan Peng, Yan-Yan Tao, Cheng-Hai Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/98d59c4b151542d492d3ff776fba87dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarkers for primary biliary cholangitis: current perspectives
por: Kouroumalis E, et al.
Publicado: (2018) -
Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
por: Satoru Joshita, et al.
Publicado: (2018) -
Update on Emerging Treatment Options for Primary Biliary Cholangitis
por: Aguilar MT, et al.
Publicado: (2020) -
Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis
por: Shogo Kitahata, et al.
Publicado: (2021) -
Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life
por: Sivakumar T, et al.
Publicado: (2021)